Benzinga | Nov 4, 2020 04:22PM EST

Anika Therapeutics Q3 Adj. EPS $0.05 Beats $(0.01) Estimate, Sales $31.70M Beat $30.11M Estimate

Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.01) by 600 percent. This is a 92.19 percent decrease over earnings of $0.64 per share from the same period last year. The company reported quarterly sales of $31.70 million which beat the analyst consensus estimate of $30.11 million by 5.28 percent. This is a 6.74 percent increase over sales of $29.70 million the same period last year.